Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Leader

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
JAMA|March 8, 2017
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery DiseaseAmit V Khera, Hong-Hee Won, Gina M Peloso, et al.
Nature|October 22, 2020
Exome sequencing and characterization of 49,960 individuals in the UK BiobankCristopher V Van Hout, Ioanna Tachmazidou, Joshua D Backman, et al.
JAMA Network Open|January 16, 2019
Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank ParticipantsKandamurugu Manickam, Adam H Buchanan, Marci L B Schwartz, et al.
Nature Genetics|August 5, 2024
Genetic risk factors for COVID-19 and influenza are largely distinctJack A Kosmicki, Anthony Marcketta, Deepika Sharma, et al.
Science (New York, N.Y.)|December 24, 2016
Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR studyFrederick E Dewey, Michael F Murray, John D Overton, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
Genome-wide analysis in 756,646 individuals provides first genetic evidence that <i>ACE2</i> expression influences COVID-19 risk and yields genetic risk scores predictive of severe diseaseJ E Horowitz, J A Kosmicki, A Damask, et al.
Nature Genetics|March 4, 2022
Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe diseaseJulie E Horowitz, Jack A Kosmicki, Amy Damask, et al.
The New England Journal of Medicine|May 25, 2017
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular DiseaseFrederick E Dewey, Viktoria Gusarova, Richard L Dunbar, et al.
Circulation Research|May 17, 2017
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart DiseaseAkihiro Nomura, Hong-Hee Won, Amit V Khera, et al.
American Journal of Human Genetics|June 11, 2021
Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individualsJack A Kosmicki, Julie E Horowitz, Nilanjana Banerjee, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
JAMA|March 8, 2017
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery DiseaseAmit V Khera, Hong-Hee Won, Gina M Peloso, et al.
Nature|October 22, 2020
Exome sequencing and characterization of 49,960 individuals in the UK BiobankCristopher V Van Hout, Ioanna Tachmazidou, Joshua D Backman, et al.
JAMA Network Open|January 16, 2019
Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank ParticipantsKandamurugu Manickam, Adam H Buchanan, Marci L B Schwartz, et al.
Nature Genetics|August 5, 2024
Genetic risk factors for COVID-19 and influenza are largely distinctJack A Kosmicki, Anthony Marcketta, Deepika Sharma, et al.
Science (New York, N.Y.)|December 24, 2016
Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR studyFrederick E Dewey, Michael F Murray, John D Overton, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
Genome-wide analysis in 756,646 individuals provides first genetic evidence that <i>ACE2</i> expression influences COVID-19 risk and yields genetic risk scores predictive of severe diseaseJ E Horowitz, J A Kosmicki, A Damask, et al.
Nature Genetics|March 4, 2022
Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe diseaseJulie E Horowitz, Jack A Kosmicki, Amy Damask, et al.
The New England Journal of Medicine|May 25, 2017
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular DiseaseFrederick E Dewey, Viktoria Gusarova, Richard L Dunbar, et al.
Circulation Research|May 17, 2017
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart DiseaseAkihiro Nomura, Hong-Hee Won, Amit V Khera, et al.
American Journal of Human Genetics|June 11, 2021
Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individualsJack A Kosmicki, Julie E Horowitz, Nilanjana Banerjee, et al.
Pageof 8